Heavy and Coppertone


Heavy Symptoms and Causes

What is fatty liver disease?

Your liver is the largest organ inside your body. It helps your body digest food, store energy, and remove poisons. Fatty liver disease is a condition in which fat builds up in your liver. There are two main types:

  • Nonalcoholic fatty liver disease (NAFLD)
  • Alcoholic fatty liver disease, also called alcoholic steatohepatitis
What is nonalcoholic fatty liver disease (NAFLD)?

NAFLD is a type of fatty liver disease that is not related to Heavy alcohol use. There are two kinds:

  • Simple fatty liver, in which you have fat in your liver but little or no inflammation or liver cell damage. Simple fatty liver typically does not get bad enough to cause liver damage or complications.
  • Nonalcoholic steatohepatitis (NASH), in which you have inflammation and liver cell damage, as well as fat in your liver. Inflammation and liver cell damage can cause fibrosis, or scarring, of the liver. NASH may lead to cirrhosis or liver cancer.
What is alcoholic fatty liver disease?

Alcoholic fatty liver disease is due to Heavy alcohol use. Your liver breaks down most of the alcohol you drink, so it can be removed from your body. But the process of breaking it down can generate harmful substances. These substances can damage liver cells, promote inflammation, and weaken your body's natural defenses. The more alcohol that you drink, the more you damage your liver. Alcoholic fatty liver disease is the earliest stage of alcohol-related liver disease. The next stages are alcoholic hepatitis and cirrhosis.

Who gets fatty liver disease?

Researchers do not know the cause of nonalcoholic fatty liver (NAFLD). They do know that it is more common in people who

  • Have type 2 diabetes and prediabetes
  • Have obesity
  • Are middle aged or older (although children can also get it)
  • Are Hispanic, followed by non-Hispanic whites. It is less common in African Americans.
  • Have high levels of fats in the blood, such as cholesterol and triglycerides
  • Have high blood pressure
  • Take certain drugs, such as corticosteroids and some cancer drugs
  • Have certain metabolic disorders, including metabolic syndrome
  • Have rapid weight loss
  • Have certain infections, such as hepatitis C
  • Have been exposed to some toxins

NAFLD affects about 25 percent of people in the world. As the rates of obesity, type 2 diabetes, and high cholesterol are rising in the United States, so is the rate of NAFLD. NAFLD is the most common chronic liver disorder in the United States.

Alcoholic fatty liver disease only happens in people who are Heavy drinkers, especially those who have been drinking for a long period of time. The risk is higher for Heavy drinkers who are women, have obesity, or have certain genetic mutations.

What are the symptoms of fatty liver disease?

Both NAFLD and alcoholic fatty liver disease are usually silent diseases with few or no symptoms. If you do have symptoms, you may feel tired or have discomfort in the upper right side of your abdomen.

How do I know if I have fatty liver disease?

Because there are often no symptoms, it is not easy to find fatty liver disease. Your doctor may suspect that you have it if you get abnormal results on liver tests that you had for other reasons. To make a diagnosis, your doctor will use

  • Your medical history
  • A physical exam
  • Various tests, including blood and imaging tests, and sometimes a biopsy

As part of the medical history, your doctor will ask about your alcohol use, to find out whether fat in your liver is a sign of alcoholic fatty liver disease or nonalcoholic fatty liver (NAFLD). He or she will also ask which medicines you take, to try to determine whether a medicine is causing your NAFLD.

During the physical exam, your doctor will examine your body and check your weight and height. Your doctor will look for signs of fatty liver disease, such as

  • An enlarged liver
  • Signs of cirrhosis, such as jaundice, a condition that causes your skin and whites of your eyes to turn yellow

You will likely have blood tests, including liver function tests and blood count tests. In some cases you may also have imaging tests, like those that check for fat in the liver and the stiffness of your liver. Liver stiffness can mean fibrosis, which is scarring of the liver. In some cases you may also need a liver biopsy to confirm the diagnosis, and to check how bad the liver damage is.

What are the treatments for fatty liver disease?

Doctors recommend weight loss for nonalcoholic fatty liver. Weight loss can reduce fat in the liver, inflammation, and fibrosis. If your doctor thinks that a certain medicine is the cause of your NAFLD, you should stop taking that medicine. But check with your doctor before stopping the medicine. You may need to get off the medicine gradually, and you might need to switch to another medicine instead.

There are no medicines that have been approved to treat NAFLD. Studies are investigating whether a certain diabetes medicine or Vitamin E can help, but more studies are needed.

The most important part of treating alcohol-related fatty liver disease is to stop drinking alcohol. If you need help doing that, you may want to see a therapist or participate in an alcohol recovery program. There are also medicines that can help, either by reducing your cravings or making you feel sick if you drink alcohol.

Both alcoholic fatty liver disease and one type of nonalcoholic fatty liver disease (nonalcoholic steatohepatitis) can lead to cirrhosis. Doctors can treat the health problems caused by cirrhosis with medicines, operations, and other medical procedures. If the cirrhosis leads to liver failure, you may need a liver transplant.

What are some lifestyle changes that can help with fatty liver disease?

If you have any of the types of fatty liver disease, there are some lifestyle changes that can help:

  • Eat a healthy diet, limiting salt and sugar, plus eating lots of fruits, vegetables, and whole grains
  • Get vaccinations for hepatitis A and B, the flu and pneumococcal disease. If you get hepatitis A or B along with fatty liver, it is more likely to lead to liver failure. People with chronic liver disease are more likely to get infections, so the other two vaccinations are also important.
  • Get regular exercise, which can help you lose weight and reduce fat in the liver
  • Talk with your doctor before using dietary supplements, such as vitamins, or any complementary or alternative medicines or medical practices. Some herbal remedies can damage your liver.

Check out the latest treatments for heavy

heavy treatment research studies

Coppertone clinical trials, surveys and public health registries

Find Drug Side Effect reports

Coppertone Side Effects

Sunburn (114)
Rash (96)
Erythema (38)
Eye Irritation (35)
Blister (33)
Accidental Exposure To Product (27)
Pain (26)
Hypersensitivity (22)
Eye Swelling (22)
Pruritus (20)
Burns Second Degree (17)
Burning Sensation (16)
Rash Pruritic (13)
Rash Erythematous (13)
Eye Pain (13)
Swelling Face (13)
Urticaria (13)
Rash Papular (12)
Ocular Hyperaemia (11)
Crying (10)
Discomfort (9)
Dry Skin (7)
Product Quality Issue (7)
Skin Discolouration (7)
Skin Irritation (6)
Feeling Hot (6)
Skin Exfoliation (6)
Hair Colour Changes (5)
Burns Third Degree (5)
Heat Stroke (5)
Insomnia (5)
Swelling (5)
Rhinorrhoea (5)
Skin Burning Sensation (5)
Rash Macular (5)
Anaphylactic Reaction (4)
Abdominal Discomfort (4)
Anaphylactic Shock (4)
Application Site Discolouration (4)
Loss Of Consciousness (4)
Skin Cancer (4)
Confusional State (3)
Caustic Injury (3)
Dermatitis Contact (3)
Chemical Injury (3)
Pain Of Skin (3)
Throat Tightness (3)
Stevens-johnson Syndrome (3)
Screaming (3)
Hyperhidrosis (3)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

After using Cooppertone Ultraguard within 24 hours my skin was itching where it had been applied. Neck felt burned and raw even though it wasn't red. The itching spread to other areas of my body where the copperton had not been applied. The itch was

First time I used the spray, I was on the beach less than two hours. It was the worst burn I have ever had. Nothing soothed it and it took forever to heal. Even after the redness went away my skin hurt. I thought that maybe the spray was old or w

I havee heavy flow of blood during menses

I innocently sprayed my 18 month old with Coppertone Sport sunscreen before going out to play a few days ago. About 15 minutes after application she got very red and looked burnt. I immediately brought her inside. Within 2 hours she looked like she h

I sprayed it on my back and a few hours I had red welts all over that area....intense itching and burning....felt odd and was in such distress I was up all night bathing with clear water and then epsom salts...I felt too dizzy and wea

I used Coppertone sport SPF 50 ultra sweatfproof formula onto arms, neck and face. After 45 minutes in the sun while working I noticed raised bumps on my sun exposed arms and neck. I'm in my fifth day with this problem.

O my god i hope i don't have it:(.

Put Coppertone SPF 8 ("non-greasy, light, fast absorbing formula") onto arms and face this morning at 9am. Drove 40 minutes to a nearby festival. After 20 minutes in the sun while watching an open event I noticed raised bumps on my sun expo

Several hours after using Coppertone Kids SPF 70 Lotion, my two year old grandson's cheeks, chin, and ears broke out in ithcy, fevered welts.

i am expiriencing heavy mentrual flow, after i have been on eltroxin for 12 months now. could it be because of this drug.

A while ago I started to feel dizzy and lightheaded I went to doctor it was my iron levels ive been on iron tablets a while and started puttin some sugar in my diet it got better until I come in my period they are heavy but ive come off now but still

After taking only 2 pills last night to fall asleep: I just could'nt wake up very heavy feeling. All morning dizzy and disorientated. My eyes feels very much irritated as well. Really this product is bad and I

Allergic reaction of sudden swelling of eyes, reddishness of eye, heavy sneezing.

Been on premique for about 3 weeks now and im experiencing some bleeding its quite heavy is that normal??


Confusion, memory loss, mood swings, eratic behavior, stomach pain, vomiting, racing heart, when dosage increased I started having heavy feeling in chest. shortness of breathchest pain. I was hospitalized, tests showed non fatal heart defect, but

DEAR SIRS I got VALDOXAN for about a month and the result so far is to getting Depression-Amnesia-heavy Thought-Shaking MORE STRESS-Dizzy MIND ETC PLEASE YOUR OPINION

Diagnosed with BV and started taking Flagyl orally twice per day for 7 days. In the 4th day of my treatment my period started. Had very heavy flow. No cramps but very heavy menstrual bleeding and passed large blood clots

Dr. started dose of 4mg once tahen blood sugar dropped quickly to level that caused sweating and dizzyness. blood checked at 60. took juice to bring level back up. heart rate increased and could feel heart beating heavy in chest. also was perscribed

Heavy Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Comparison of Standard and Minidose Spinal Anesthesia for Cesarean Section Operation Using Marcaine Spinal 0.5% Heavy
Conditions: Cesarean Section;   Anesthesia, Spinal;   Local Anaesthetics Causing Adverse Effects in Therapeutic Use
Interventions: Drug: Bupivacaine and Fentanyl;   Drug: Bupivacaine
Outcome Measures: prominence of motor blockade;   operative condition;   intraoperative hypotension;   need for postoperative pain medication;   general patient satisfaction
2 Not yet recruiting Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention: Radiation: Heavy ion radiotherapy (C12)
Outcome Measures: feasibility, toxicity (tox) measured by the CTC Criteria .Unacceptable:grade 4 tox. A rate of acute tox (≤ 3 months during/after RT) > grade 3 of ≤ 5% and a rate of late tox > grade 3 of ≤ 3% will be acceptable.;   tumor response (RECIST criteria), disease free survival, overall survival and description of FDG-PET characteristics before and after RT.
3 Recruiting Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Conditions: Male Breast Cancer;   Neurotoxicity;   Peripheral Neuropathy;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Other: laboratory biomarker analysis;   Other: questionnaire administration
Outcome Measures: Level of Heavy metal in blood and urine;   Incidence of high grade neurotoxicity, defined as grade >= 3 peripheral neuropathy, graded according to CTCAE v. 4.0
4 Recruiting Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
Condition: Reduction in Heavy Drinking in Patients With HIV
Interventions: Drug: Naltrexone;   Other: Placebo + Medication Management/Medication Coaching
Outcome Measures: To compare the efficacy of NTX +MM/MC versus placebo +MM/MC on adherence to HAART.;   To compare the efficacy of NTX +MM/MC versus placebo +MM/MC in reducing days of Heavy drinking.
5 Recruiting Zonisamide for Heavy Drinkers With Bipolar Disorder
Conditions: Alcohol Use Disorders;   Bipolar Disorder
Interventions: Drug: Zonisamide;   Drug: Placebo
Outcome Measures: Percentage of total Heavy Drinking Days;   Change on Hamilton Depression Rating Scale;   Change in Clinician Assisted Rating Scale for Mania (CARS-M) Scores;   Percentage of Abstinent Days;   Change in Alcohol Urge Questionnaire Score;   Change in Gamma glutamyl transferase (GGT);   Change in Beck Depression Inventory (BDI) Scores;   Percentage of total drinking days;   Change in number of Heavy drinking days per week by time;   Change in number of drinks per week by time
6 Recruiting Dexmedetomidine in Spinal Anesthesia
Conditions: Blood Pressure;   Anxiety
Interventions: Drug: Dexmedetomidine;   Drug: Dexmedetomidine with Heavy bupivacaine
Outcome Measures: Hemodynamic effects;   Patient's comfortability and anxiety
7 Recruiting Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
Conditions: Heavy Uterine Bleeding;   Uterine Fibroids
Interventions: Other: Placebo;   Drug: Elagolix;   Drug: Estradiol/norethindrone acetate, E2/NETA;   Drug: Estradiol/norethindrone acetate, E2/NETA Dose 2;   Drug: Estradiol/norethindrone acetate
Outcome Measures: Change in Menstrual Blood Loss;   Change in Physical Examination;   Change from Baseline in the number of subjects with adverse events;   Change in Bone Mineral Density (BMD);   Change in Endometrial Assessment;   Change in Clinical Laboratory Tests;   Percentage of Subjects with reduction in Menstrual Blood Loss;   Percentage Subjects with amenorrhea;   Percentage of Subjects with No Bleeding (spotting allowed);   Number of Bleeding Days;   Percent Change from baseline in bleeding scores per bleeding diary;   Percent Change in Uterine Volume;   Percent Change in Fibroid Volume;   Percent change in hemoglobin concentration;   Change in bone mineral density;   Change in percentage of subjects with hypoestrogenic effects;   Proportion reporting treatment-emergent adverse events;   Change from Baseline in the percent of subjects with adverse events
8 Recruiting New Approaches to Smoking Cessation in Heavy Drinkers
Conditions: Nicotine Dependence;   Cigarette Smoking;   Alcohol Consumption;   Heavy Drinking
Intervention: Drug: Varenicline
Outcome Measures: Evaluate feasibility and acceptability of cognitive-behavioral therapy (CBT) for smoking and alcohol (SA);   Smoking Abstinence;   Reductions in drinking
9 Recruiting Tranexamic Acid in Adolescents With Heavy Menstrual Bleeding
Condition: Heavy Menstrual Bleeding
Intervention: Drug: Tranxemic Acid
Outcome Measures: Quality of Life;   Menstrual blood loss, change in hemoglobin, and ferritin concentrations.
10 Unknown  Pretreatment With Norethindrone Acetate Prior to Levonorgestrel IUS Insertion for Heavy Menstrual Bleeding
Conditions: Heavy Menstrual Bleeding;   Menorrhagia;   Hypermenorrhea
Interventions: Drug: Norethindrone acetate pretreatment;   Other: No pretreatment
Outcome Measures: Total number of bleeding days;   Menorrhagia Questionnaire
11 Not yet recruiting A Web Application to Reduce Heavy Drinking in First-time DWI Offenders
Conditions: Driving While Intoxicated;   Driving Under the Influence;   Heavy Drinking;   Alcohol Abstinence
Interventions: Behavioral: Right Turns web application;   Behavioral: Treatment as usual
Outcome Measures: Quantity/frequency of alcohol use: Form 90;   Inventory of Drug Use Consequences (InDuC);   Self-efficacy
12 Not yet recruiting Topiramate's Effects on Heavy Drinking
Condition: Alcohol Drinking
Interventions: Drug: Topiramate;   Drug: Placebo
Outcome Measures: fMRI response in the ventral striatum/medial orbitofrontal cortex during alcohol cue exposure;   Drinking days;   change in gamma-glutamyl transferase (GGT) or carbohydrate-deficient transferrin (CDT) levels;   Heavy drinking days;   Mean alcohol consumption
13 Recruiting Estradiol vs Lysteda in Treatment of Heavy Menstrual Bleeding
Condition: Menstrual Cycle and Uterine Bleeding Disorders
Interventions: Drug: Estradiol;   Drug: Lysteda
Outcome Measures: menstrual blood loss;   changes in local hemostatic factors
14 Recruiting Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Condition: Metrorrhagia
Interventions: Drug: EV/DNG (Qlaira, Natazia, BAY86-5027);   Drug: placebo
Outcome Measures: Absolute change in Menstrual Blood Loss (MBL) at baseline and 90 days;   Proportion of subjects with successful treatment;   Percent change of MBL at baseline and 90 day period during treatment phase;   Absolute change of average MBL at baseline and up to cycle 7 (one cycle = 28 days);   Proportion of subjects with improvement in the investigator's global assessment scale on Day 84;   Proportion of subjects with improvement in the investigator's global assessment scale on Day 196;   Proportion of subjects with improvement in the subject's global assessment scale on Day 84;   Proportion of subjects with improvement in the subject's global assessment scale on Day 196;   Number of participants with adverse events as a measure of safety and tolerability
15 Recruiting HMB- Data Collection Methods
Condition: Heavy Menstrual Bleeding
Interventions: Other: Web-based data collection;   Other: Paper-based data collection
Outcome Measures: Quality of Life;   Quality of data collected
16 Not yet recruiting Dexamethasone for Excessive Menstruation
Condition: Heavy Menstrual Bleeding
Interventions: Drug: Dexamethasone;   Drug: placebo
Outcome Measures: Change or difference in mean laboratory measured menstrual blood loss(MBL);   Menstrual diary score for volume of menstrual period;   Satisfaction with treatment by means of a participant completed treatment review questionnaire;   Number of participants with adverse events as a measure of safety and tolerability;   Examine effect of treatment on Period pain via participant self-report questionnaire;   Mechanistic examination of response to Dexamethasone
17 Recruiting Physical Activity as Intervention Against Age-related Loss of Muscle Mass and Function
Conditions: Muscle Weakness;   Muscle Loss;   Sarcopenia;   Physical Activity
Interventions: Procedure: Heavy resistance training;   Biological: Moderate intensity training;   Biological: Control;   Behavioral: Physical activity level
Outcome Measures: Change in leg extensor power;   Change in quadriceps cross sectional area;   Change in maximal isometric quadriceps strength;   Change in 30 s chair stand performance;   Change in 400 m gait speed;   Change in whole body composition and bone mineral density;   Change in grip strength;   Change in perceived age;   Change in blood parameters and anthropometry;   Change in physical activity level;   Change in Exercise self-efficacy;   Change in Health Related Quality of Life;   Changes in brain structure and function;   Change in cognitive ability;   Change in personality;   Change in mental symptoms
18 Recruiting Counteracting Age-related Loss of Skeletal Muscle Mass
Conditions: Sarcopenia;   Muscle Loss
Interventions: Procedure: Heavy Resistance Training;   Procedure: Light Intensity Training;   Dietary Supplement: Protein Whey;   Dietary Supplement: Protein Collagen;   Dietary Supplement: Carbohydrate
Outcome Measures: Change in muscle cross sectional area;   Change in quadriceps muscle isometric strength;   Change in quadriceps muscle isokinetic strength;   Change in leg extension muscle power;   Change from baseline in muscle structure and signalling;   Change in gut microbiota composition.;   Change in faecal metabolome.;   Change in plasma metabolome.;   Change in 30 s chair stand;   Change in whole body composition and bone mineral density
19 Recruiting Counteracting Age-related Loss of Skeletal Muscle Mass (CALM)
Conditions: Sarcopenia;   Muscle Loss
Interventions: Procedure: Heavy Resistance Training;   Procedure: Light Intensity Training;   Dietary Supplement: Protein Whey;   Dietary Supplement: Protein Collagen;   Dietary Supplement: Carbohydrate
Outcome Measures: 4 h basal muscle protein synthesis;   3 d muscle protein synthesis;   7 d muscle protein breakdown;   Muscle protein turnover molecular signaling and gene expression
20 Recruiting Stopping Heavy Periods Project
Conditions: Abnormal Uterine Bleeding;   Abnormal Uterine Bleeding, Ovulatory Dysfunction;   Abnormal Uterine Bleeding, Endometrial Hemostatic Dysfunction
Interventions: Device: Levonorgestrel intrauterine system;   Drug: Combined oral contraceptives
Outcome Measures: Menstrual Bleeding Questionnaire;   Treatment Failure